Leukocytoclastic vasculitis

被引:0
|
作者
Sunderkötter, C
Roth, J
Bonsmann, G
机构
[1] Univ Ulm Klinikum, Univ Klin & Poliklin Dermatol & Allergol, D-89081 Ulm, Germany
[2] Univ Klinikum Munster, Inst Expt Dermatol, Munster, Germany
[3] Univ Klinikum Munster, Univ Kinderklin, Munster, Germany
[4] Univ Klinikum Munster, Klin & Poliklin Hautkrankheiten, Munster, Germany
来源
HAUTARZT | 2004年 / 55卷 / 08期
关键词
leukocytoclastic vasculitis; purpura; immune complex; Henoch-Schonlein purpura; hypersensitivity vasculitis; ANCA;
D O I
10.1007/s00105-004-0760-1
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Leukocytoclastic vasculitis (LcV) is the most common form of cutaneous vasculitis. Often LcV results from deposition of immune complexes in the vascular wall. When IgA is the dominant immunoglobulin in these complexes, systemic involvement is likely (Henoch-Schonlein purpura), being more severe in adults. LcV in which immune complexes are composed of IgG or IgM are more often limited to the skin and may additionally show minor systemic involvement. in other forms of LcV additional pathophysiological factors play a role. LcV can also be a presenting or accompanying symptom of severe systemic ANCA-associated vasculitis. in some cases, LcV is a sign of bacteriemia. The aim of diagnostic procedures is to determine the specific type of vasculitis and degree of systemic involvement as well as possible causes. If no trigger or cause can be found, uncomplicated cases of LcV should be treated symptomatically. Corticosteroids are indicated at initial signs of necrosis or ulceration. Chronic recurrent LcV may respond to dapsone or colchicine. Severe systemic vasculitis requires immunosuppressive therapy.
引用
收藏
页码:759 / 783
页数:25
相关论文
共 50 条
  • [1] Leukocytoclastic vasculitis
    Sunderkötter C.
    Roth J.
    Bonsmann G.
    Der Hautarzt, 2004, 55 (8): : 759 - 785
  • [2] Ceftriaxone-induced leukocytoclastic vasculitis: a case report and literature review of antibiotic-induced leukocytoclastic vasculitis
    Almasoudi, Aseel A.
    Bablghaith, Eman S.
    Alaauldeen, Samaher, I
    Falemban, Ayman M.
    Sherbeeni, Ahlam A.
    Bulkhi, Adeeb A.
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2022, 50 (05)
  • [3] Cinacalcet-Induced Leukocytoclastic Vasculitis
    Giannikopoulos, George
    Zorzou, Markela-Pagonitsa
    Stamoulis, Ioannis
    Panagi, Georgia
    Sitaras, Panagiotis
    Georgopoulos, Ioannis
    Hadjileontis, Constantinos
    Malakos, Ioannis
    Kyriazis, John
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2009, 54 (02) : E5 - E8
  • [4] Hypersensitivity vasculitis with leukocytoclastic vasculitis secondary to infliximab
    McIlwain, L
    Carter, JD
    Bin-Sagheer, S
    Vasey, FB
    Nord, J
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2003, 36 (05) : 411 - 413
  • [5] Cephalexin-Induced Leukocytoclastic Vasculitis
    Tang, Wesley
    Tan, Jennie
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (07)
  • [6] Vancomycin-Induced Leukocytoclastic Vasculitis
    Felix-Getzik, Erika
    Sylvia, Lynne M.
    PHARMACOTHERAPY, 2009, 29 (07): : 846 - 851
  • [7] Management of leukocytoclastic vasculitis
    Sunderkötter, C
    Bonsmann, G
    Sindrilaru, A
    Luger, T
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2005, 16 (04) : 193 - 206
  • [8] Annular leukocytoclastic vasculitis: A particular form of small vessel vasculitis?
    Moawad, S.
    Bursztejn, A. -C.
    Schmutz, J. -L.
    Barbaud, A.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2016, 143 (05): : 364 - 368
  • [9] Propylthiouracil-Induced Thrombotic Leukocytoclastic Vasculitis
    Kutluturk, Faruk
    Gul, Nurdan
    Yarman, Sema
    Tanakol, Refik
    Alagol, Faruk
    TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2006, 10 (02) : 45 - 47
  • [10] Cutaneous Leukocytoclastic Vasculitis, Henoch-Schonlein Purpura and Cryoglobulinemic Vasculitis
    Unger, S. I.
    Baerwald, C.
    AKTUELLE RHEUMATOLOGIE, 2013, 38 (05) : 294 - 299